Table 2 Baseline characteristics (n = 97)
N (%) | |
|---|---|
Median age at diagnosis (range) | 63 (20–92) |
Histological subtype | |
High-grade serous | 90 (92.7) |
High-grade endometrioid | 5 (5.2) |
Clear cell | 2 (2.1) |
FIGO stage at diagnosis | |
I | 7 (7.2) |
II | 4 (4.1) |
III | 73 (75.3) |
IV | 13 (13.4) |
ER-status | |
Positive | 50 (51.5) |
Negative | 1 (1) |
Unknown | 46 (47.4) |
PR-status | |
Positive | 20 (20.1) |
Negative | 11 (11.3) |
Unknown | 66 (68) |
Primary Surgery status | |
Complete debulking | 37 (38.1) |
Suboptimal debulking (>1 cm residual disease) | 44 (45.3) |
No surgery | 16 (16.5) |
Platinum-sensitivity | |
Platinum-sensitive | 39 (40) |
Platinum-resistant | 58 (60) |
Number of lines of prior chemotherapy | |
1 | 18 (18.6) |
2 | 15 (15.5) |
3 | 21 (21.6) |
4 | 17 (17.5) |
5 | 10 (10.3) |
≥ 6 | 16 (16.5) |